Literature DB >> 28246192

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia.

Guillermo Montalban-Bravo1, Christopher B Benton1, Sa A Wang2, Farhad Ravandi1, Tapan Kadia1, Jorge Cortes1, Naval Daver1, Koichi Takahashi1, Courtney DiNardo1, Elias Jabbour1, Gautam Borthakur1, Marina Konopleva1, Sherry Pierce1, Carlos Bueso-Ramos2, Keyur Patel2, Steven Kornblau1, Hagop Kantarjian1, Ken H Young2, Guillermo Garcia-Manero1, Michael Andreeff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28246192      PMCID： PMC5418636          DOI： 10.1182/blood-2016-11-749903

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  22 in total

Review 1.  Minimally differentiated erythroleukemia: recognition of erythroid precursors and progenitors.

Authors:  T Shichishima
Journal:  Intern Med       Date:  2000-10       Impact factor: 1.271

Review 2.  Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7.

Authors:  B A Peterson; E G Levine
Journal:  Semin Oncol       Date:  1987-12       Impact factor: 4.929

Review 3.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

4.  Minimally differentiated erythroleukaemia (AML M6 'variant'): a rare subset of AML distinct from AML M6. Groupe Français d'Hématologie Cellulaire.

Authors:  R Garand; E Duchayne; D Blanchard; N Robillard; E Kuhlein; O Fenneteau; F Salomon-Nguyen; M J Grange; P Rousselot; C Demur
Journal:  Br J Haematol       Date:  1995-08       Impact factor: 6.998

5.  Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.

Authors:  F P S Santos; S Faderl; G Garcia-Manero; C Koller; M Beran; S O'Brien; S Pierce; E J Freireich; X Huang; G Borthakur; C Bueso-Ramos; M de Lima; M Keating; J Cortes; H Kantarjian; F Ravandi
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

Review 6.  Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.

Authors:  Rashmi Kanagal-Shamanna; Rajesh R Singh; Mark J Routbort; Keyur P Patel; L Jeffrey Medeiros; Rajyalakshmi Luthra
Journal:  Expert Rev Mol Diagn       Date:  2016-02-15       Impact factor: 5.225

7.  Phenotype of early erythroblastic leukemias.

Authors:  J L Villeval; P Cramer; F Lemoine; A Henri; A Bettaieb; F Bernaudin; Y Beuzard; R Berger; G Flandrin; J Breton-Gorius
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

8.  TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.

Authors:  Chi Young Ok; Keyur P Patel; Guillermo Garcia-Manero; Mark J Routbort; Jie Peng; Guilin Tang; Maitrayee Goswami; Ken H Young; Rajesh Singh; L Jeffrey Medeiros; Hagop M Kantarjian; Rajyalakshmi Luthra; Sa A Wang
Journal:  J Hematol Oncol       Date:  2015-05-08       Impact factor: 17.388

9.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

10.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962
View more
  17 in total

Review 1.  Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia.

Authors:  Yahya Daneshbod; Leila Kohan; Vahideh Taghadosi; Olga K Weinberg; Daniel A Arber
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

2.  Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice.

Authors:  Keith R Loeb; Bridget T Hughes; Brian M Fissel; Nyka J Osteen; Sue E Knoblaugh; Jonathan E Grim; Luke J Drury; Aaron Sarver; Adam J Dupuy; Bruce E Clurman
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

3.  Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias.

Authors:  Nathalie Cervera; Anne-Catherine Lhoumeau; José Adélaïde; Arnaud Guille; Anne Murati; Marie-Joëlle Mozziconacci; Norbert Vey; Daniel Birnbaum; Véronique Gelsi-Boyer
Journal:  Haematologica       Date:  2019-10-10       Impact factor: 9.941

4.  De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.

Authors:  Erica F Reinig; Patricia T Greipp; April Chiu; Matthew T Howard; Kaaren K Reichard
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 5.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 6.  The International Consensus Classification of acute myeloid leukemia.

Authors:  Olga K Weinberg; Anna Porwit; Attilio Orazi; Robert P Hasserjian; Kathryn Foucar; Eric J Duncavage; Daniel A Arber
Journal:  Virchows Arch       Date:  2022-10-20       Impact factor: 4.535

Review 7.  Erythroleukemia-historical perspectives and recent advances in diagnosis and management.

Authors:  Prajwal Boddu; Christopher B Benton; Wei Wang; Gautam Borthakur; Joseph D Khoury; Naveen Pemmaraju
Journal:  Blood Rev       Date:  2017-09-18       Impact factor: 8.250

8.  Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

Authors:  Alexandre Fagnan; Frederik Otzen Bagger; Maria-Riera Piqué-Borràs; Cathy Ignacimouttou; Alexis Caulier; Cécile K Lopez; Elie Robert; Benjamin Uzan; Véronique Gelsi-Boyer; Zakia Aid; Cécile Thirant; Ute Moll; Samantha Tauchmann; Amina Kurtovic-Kozaric; Jaroslaw Maciejewski; Christine Dierks; Orietta Spinelli; Silvia Salmoiraghi; Thomas Pabst; Kazuya Shimoda; Virginie Deleuze; Hélène Lapillonne; Connor Sweeney; Véronique De Mas; Betty Leite; Zahra Kadri; Sébastien Malinge; Stéphane de Botton; Jean-Baptiste Micol; Benjamin Kile; Catherine L Carmichael; Ilaria Iacobucci; Charles G Mullighan; Martin Carroll; Peter Valent; Olivier A Bernard; Eric Delabesse; Paresh Vyas; Daniel Birnbaum; Eduardo Anguita; Loïc Garçon; Eric Soler; Juerg Schwaller; Thomas Mercher
Journal:  Blood       Date:  2020-08-06       Impact factor: 25.476

9.  Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.

Authors:  N Cervera; N Carbuccia; M-J Mozziconacci; J Adélaïde; S Garnier; A Guille; A Murati; M Chaffanet; N Vey; D Birnbaum; V Gelsi-Boyer
Journal:  Blood Cancer J       Date:  2017-08-25       Impact factor: 11.037

10.  Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.

Authors:  Paolo Sportoletti; Daniele Sorcini; Anna G Guzman; Jaime M Reyes; Arianna Stella; Andrea Marra; Sara Sartori; Lorenzo Brunetti; Roberta Rossi; Beatrice Del Papa; Francesco Maria Adamo; Giulia Pianigiani; Camilla Betti; Annarita Scialdone; Valerio Guarente; Giulio Spinozzi; Valentina Tini; Maria Paola Martelli; Margaret A Goodell; Brunangelo Falini
Journal:  Leukemia       Date:  2020-11-06       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.